MX9604803A - Combinacion de hormona del crecimiento y factor de crecimiento similar a insulina para el tratamiento del fallo cardiaco congestivo. - Google Patents

Combinacion de hormona del crecimiento y factor de crecimiento similar a insulina para el tratamiento del fallo cardiaco congestivo.

Info

Publication number
MX9604803A
MX9604803A MX9604803A MX9604803A MX9604803A MX 9604803 A MX9604803 A MX 9604803A MX 9604803 A MX9604803 A MX 9604803A MX 9604803 A MX9604803 A MX 9604803A MX 9604803 A MX9604803 A MX 9604803A
Authority
MX
Mexico
Prior art keywords
combination
heart failure
mammal
congestive heart
insulin
Prior art date
Application number
MX9604803A
Other languages
English (en)
Other versions
MXPA96004803A (es
Inventor
Ross G Clark
Hongkui Jin
Nicholas F Paoni
Renhui Yang
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/284,859 external-priority patent/US5661122A/en
Priority claimed from US08/333,909 external-priority patent/US5610134A/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of MXPA96004803A publication Critical patent/MXPA96004803A/es
Publication of MX9604803A publication Critical patent/MX9604803A/es

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se describen métodos para mejorar la capacidad de contraccion del miocardio y el funcionamiento cardíaco en un mamífero con fallo cardíaco congestivo. En un primer método, el mamífero con un fallo cardíaco congestivo es tratado mediante administracion al mamífero de una cantidad efectiva de una combinacion de hormona del crecimiento (GH) y factor de crecimiento similar a insulina (IGF-I). Un segundo método comprende administrar al mamífero una cantidad efectiva de una combinacion de GH e IGF-I en presencia de un inhibidor de ACE. Este método resulta en una mejora en la capacidad de contraccion del miocardio y un funcionamiento cardíaco por encima del nivel que se obtiene con la inhibicion de ACE sola. De manera preferible, el mamífero es un humano.
MX9604803A 1994-08-02 1995-03-30 Combinacion de hormona del crecimiento y factor de crecimiento similar a insulina para el tratamiento del fallo cardiaco congestivo. MX9604803A (es)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US333090 1981-12-21
US227923 1994-04-15
US227,923 1994-04-15
US08/284,859 US5661122A (en) 1994-04-15 1994-08-02 Treatment of congestive heart failure
US08284859 1994-08-02
US08/333,909 US5610134A (en) 1994-04-15 1994-11-03 Treatment of congestive heart failure
US333,090 1994-11-03
PCT/US1995/003755 WO1995028174A1 (en) 1994-04-15 1995-03-30 The combination of growth hormone and insulin-like growth factor, for treating congestive heart failure

Publications (2)

Publication Number Publication Date
MXPA96004803A MXPA96004803A (es) 1998-02-01
MX9604803A true MX9604803A (es) 1998-02-28

Family

ID=39166704

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9604803A MX9604803A (es) 1994-08-02 1995-03-30 Combinacion de hormona del crecimiento y factor de crecimiento similar a insulina para el tratamiento del fallo cardiaco congestivo.

Country Status (1)

Country Link
MX (1) MX9604803A (es)

Similar Documents

Publication Publication Date Title
HK1003418A1 (en) The combination of growth hormone and insulin-like growth factor, for treating congestive heart failure
MD1558F2 (en) Method of prophylaxis of mammal acute renal insufficiency utilizing IGF-I insulin-like growth factor
MY133569A (en) Method of reducing tissue damage associated with non-cardiac ischemia using glycogen phosphorylase inhibitors
PL338705A1 (en) Application of gaba analogues in preventing and treating gastrointestinal diseases
ES8600062A1 (es) Un metodo para inhibir la mineralizacion de un tejido natural
EP0103947A3 (en) Method for inhibiting mineralization of natural tissue during implantation
ID17768A (id) Metoda pengobatan
HK1007954A1 (en) The combination of growth hormone and insulin-like growth factor-i enhances growth
DK0670729T3 (da) Anvendelse af insulin-lignende vækstfaktorer og analoger til behandling af retinale nervesygdomme
GR3033667T3 (en) Use of non-steroidal cyclooxygenase inhibitors to treat elevated intraocular pressure
WO2003020202A3 (en) Method for reducing hypertension and heart failure
CA2088254A1 (en) Treatment for hypercholesterolemia
AU2209300A (en) Method of stimulating growth in aquatic animals using growth hormones
EP0751954A4 (en) ANTI-INFLAMMATION COMPOSITION AND METHOD IN WHICH DES-TYR DYNORPHINE AND ANALOGUE ARE USED
CA2032859A1 (en) Method of reducing or preventing adverse effect of steroid therapy and compositions therefor
MX9604803A (es) Combinacion de hormona del crecimiento y factor de crecimiento similar a insulina para el tratamiento del fallo cardiaco congestivo.
PL329077A1 (en) Method of treating cardiac insufficiency by means of endotelin antagonists
ES2138561A1 (es) Uno de los peptidos vip pacap en el tratamiento del abock endotoxico en mamiferos.
EP0788799A3 (en) LHRH-Antagonists in the treatment of fertility disorders
NO830041L (no) Fremgangsmaate til behandling av azykli hos sauer eller storfe
EP1056458A4 (en) METHODS FOR TREATING PAIN, INCLUDING CHRONIC AND WOMAN-SPECIFIC PAIN
ATE137407T1 (de) Behandlung von intraocularem druck mit einer synergistischen kombination
MY118982A (en) Method of reducing tissue damage associated with ischemia
WO1995005364A3 (en) Inhibitors of biogenic amine transporters
WO2001007025A3 (en) Treatment of cardiac abnormalities with aryloxy propanolamines